Citadel Advisors’s ProShares Ultra NVDA NVDB Stock Holding History

Citadel Advisors’s Portfolio NVDB Stock Details NVDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$488K	Buy	21,354 +1,569	+8%	+$41.5K	﹤0.01%	9376
2025 Q4	$557K	Buy	+19,785	New	+$576K	﹤0.01%	8768

Other funds holding NVDB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's NVDB Position: Q1 2026 in Review

Citadel Advisors increased its ProShares Ultra NVDA (NVDB) stake by 7.9% in Q1 2026, buying an estimated $41.5K and bringing the position to 21,354 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #9376.

Citadel Advisors first reported a position in NVDB in Q4 2025 and has held it in 2 quarters since. The position peaked at $557K in Q4 2025. 5 funds tracked by Wall St. Rank hold NVDB as of Q1 2026.

Citadel Advisors held 21,354 shares of ProShares Ultra NVDA worth $488K as of Q1 2026.
Citadel Advisors bought 1,569 ProShares Ultra NVDA shares in Q1 2026, an estimated $41.5K.
ProShares Ultra NVDA made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9376 holding.
Citadel Advisors first reported a position in ProShares Ultra NVDA in Q4 2025 and has held it in 2 quarters since.
Citadel Advisors's ProShares Ultra NVDA position peaked at $557K in Q4 2025.
5 funds tracked by Wall St. Rank held ProShares Ultra NVDA as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.